Companies / ELI LILLY & Co / Activity
Activity — ELI LILLY & Co
107 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 16, 2026 | Brown Adrienne S Executive | Exercise | Common Stock | $0 | +391 +7.95% | 5,312 <0.01% of shares | low |
| Feb 16, 2026 | Custer Kenneth L. Executive | Exercise | Common Stock | $0 | +207 +2.06% | 10,232 <0.01% of shares | low |
| Feb 19, 2026 | Dozier Eric Executive | Gift | Common Stock | $0 | -481 -3.22% | 14,455 <0.01% of shares | low |
| Feb 1, 2026 | Dozier Eric Executive | Exercise | Common Stock | $0 | +3K +29.05% | 12,697 <0.01% of shares | low |
| Feb 1, 2026 | Hernandez Edgardo Executive | Exercise | Common Stock | $0 | +4K +8.99% | 43,303 <0.01% of shares | low |
| Feb 1, 2026 | Rau Diogo Executive | Exercise | Common Stock | $0 | +4K +19.03% | 23,471 <0.01% of shares | low |
| Feb 1, 2026 | Yuffa Ilya Executive | Exercise | Common Stock | $0 | +3K +12.92% | 29,654 <0.01% of shares | low |
| Feb 1, 2026 | Jonsson Patrik Executive | Exercise | Common Stock | $0 | +4K +7.33% | 57,581 <0.01% of shares | low |
| Feb 16, 2026 | Montarce Lucas Executive | Exercise | Common Stock | $0 | +368 +2.29% | 16,418 <0.01% of shares | low |
| Feb 1, 2026 | Skovronsky Daniel Executive | Exercise | Common Stock | $0 | +13K +9.23% | 150,165 0.02% of shares | low |
| Feb 1, 2026 | Hakim Anat Executive | Exercise | Common Stock | $0 | +7K +61.12% | 17,663 <0.01% of shares | low |
| Feb 1, 2026 | Van Naarden Jacob Executive | Exercise | Common Stock | $0 | +4K +19.98% | 24,670 <0.01% of shares | low |
| Feb 16, 2026 | Zakrowski Donald A Executive | Exercise | Common Stock | $0 | +184 +5.37% | 3,607 <0.01% of shares | low |
| Feb 1, 2026 | Ricks David A CEO | Exercise | Common Stock | $0 | +32K +6.20% | 547,098 0.06% of shares | low |
| May 18, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +5 +0.17% | 2,987 <0.01% of shares | low |
| Apr 20, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +5 +0.18% | 2,982 <0.01% of shares | low |
| Jun 15, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +4 +0.15% | 2,995 <0.01% of shares | low |
| Mar 16, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +5 +0.17% | 2,976 <0.01% of shares | low |
| Feb 17, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +5 +0.16% | 2,966 <0.01% of shares | low |
| Jan 20, 2026 | Sulzberger Gabrielle Director | Grant | Common Stock | $5.0K | +5 +0.16% | 2,961 <0.01% of shares | low |
| Jan 20, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +10 +0.01% | 75,111 <0.01% of shares | low |
| May 18, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +10 +0.01% | 75,280 <0.01% of shares | low |
| Apr 20, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +11 +0.01% | 75,270 <0.01% of shares | low |
| Jun 15, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +9 +0.01% | 75,401 <0.01% of shares | low |
| Mar 16, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +10 +0.01% | 75,259 <0.01% of shares | low |
| Feb 17, 2026 | Fyrwald J Erik Director | Grant | Common Stock | $9.9K | +10 +0.01% | 75,120 <0.01% of shares | low |
| May 18, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +13 +0.02% | 55,627 <0.01% of shares | low |
| Jan 20, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +12 +0.02% | 55,480 <0.01% of shares | low |
| Mar 16, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +13 +0.02% | 55,601 <0.01% of shares | low |
| Jun 15, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +11 +0.02% | 55,723 <0.01% of shares | low |
| Apr 20, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +13 +0.02% | 55,615 <0.01% of shares | low |
| Feb 17, 2026 | Alvarez Ralph Director | Grant | Common Stock | $12.4K | +12 +0.02% | 55,492 <0.01% of shares | low |
| Feb 17, 2026 | Luciano Juan R Director | Grant | Common Stock | $15.9K | +15 +0.09% | 16,772 <0.01% of shares | low |
| Mar 16, 2026 | Luciano Juan R Director | Grant | Common Stock | $15.9K | +16 +0.10% | 16,817 <0.01% of shares | low |
| Jan 20, 2026 | Luciano Juan R Director | Grant | Common Stock | $15.9K | +15 +0.09% | 16,757 <0.01% of shares | low |
| Feb 16, 2026 | Zakrowski Donald A Executive | Other | Common Stock | $84.8K | -82 -2.26% | 3,526 <0.01% of shares | low |
| Feb 16, 2026 | Custer Kenneth L. Executive | Other | Common Stock | $95.0K | -91 -0.89% | 10,141 <0.01% of shares | low |
| Feb 16, 2026 | Montarce Lucas Executive | Other | Common Stock | $166.1K | -160 -0.97% | 16,258 <0.01% of shares | low |
| Feb 16, 2026 | Brown Adrienne S Executive | Other | Common Stock | $176.8K | -170 -3.20% | 5,142 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $459.8K | -420 -0.00% | 92,170,934 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $520.5K | -475 -0.00% | 92,170,459 9.79% of shares | medium |
| Feb 9, 2026 | Zakrowski Donald A Executive | Grant | Common Stock | $609.9K | +584 +20.56% | 3,423 <0.01% of shares | low |
| Feb 9, 2026 | Custer Kenneth L. Executive | Grant | Common Stock | $688.7K | +659 +7.04% | 10,025 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $971.2K | -895 -0.00% | 92,188,231 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.01M | -930 -0.00% | 92,178,547 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.16M | -1K -0.00% | 92,179,477 9.79% of shares | medium |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.17M | -1K -0.00% | 92,172,676 9.79% of shares | medium |
| Feb 9, 2026 | Brown Adrienne S Executive | Grant | Common Stock | $1.25M | +1K +32.12% | 4,921 <0.01% of shares | low |
| Feb 1, 2026 | Dozier Eric Executive | Other | Common Stock | $1.32M | -1K -10.03% | 11,424 <0.01% of shares | low |
| Jan 7, 2026 | Lilly Endowment, Inc. 10% owner | Sell | Common Stock | $1.34M | -1K -0.00% | 92,173,748 9.79% of shares | medium |